BPBT
CLB icon

Boston Private Bank & Trust’s Core Laboratories CLB Stock Holding History

Boston Private Bank & Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-25
Closed -$3K – 1075
2014
Q4 		$3K Hold
25
– – ﹤0.01% 1005
2014
Q3 		$4K Sell
25
-40
-62% -$6.17K ﹤0.01% 962
2014
Q2 		$11K Hold
65
– – ﹤0.01% 807
2014
Q1 		$13K Buy
65
+25
+63% +$4.72K ﹤0.01% 809
2013
Q4 		$8K Sell
40
-60
-60% -$11.2K ﹤0.01% 869
2013
Q3 		$17K Hold
100
– – ﹤0.01% 726
2013
Q2 		$15K Buy
+100
New +$14.2K ﹤0.01% 707

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Boston Private Bank & Trust's CLB Position: Q1 2015 in Review

Boston Private Bank & Trust sold out of Core Laboratories (CLB) in Q1 2015, closing a stake of 25 shares — an estimated $3K sold.

Boston Private Bank & Trust first reported a position in CLB in Q2 2013 and held it in 7 quarters. The position peaked at $17K in Q3 2013. 348 funds tracked by Wall St. Rank hold CLB as of Q1 2015.

  • Boston Private Bank & Trust reported no remaining Core Laboratories position as of Q1 2015 after selling out during the quarter.
  • Boston Private Bank & Trust sold 25 Core Laboratories shares in Q1 2015, an estimated $3K.
  • Boston Private Bank & Trust first reported a position in Core Laboratories in Q2 2013 and held it in 7 quarters.
  • Boston Private Bank & Trust's Core Laboratories position peaked at $17K in Q3 2013.
  • 348 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.